EZH2 and non-small cell lung carcinoma: Yuan et al. showed that over-expression of LINC00662 in non-small cell lung cancer is driven by copy number amplification and drives tumor growth in vitro and in vivo via recruitment of EZH2 on target gene promoters [40].